1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Asthma Drugs Market, by Product
6.1. Introduction
6.2. Long-term control medications
6.3. Medications for allergy-induced asthma
6.4. Quick-relief medications (rescue medications)

7. Asthma Drugs Market, by Application
7.1. Introduction
7.2. Hospital Pharmacy
7.3. Online Pharmacy
7.4. Retail Pharmacy

8. California Asthma Drugs Market

9. Florida Asthma Drugs Market

10. Illinois Asthma Drugs Market

11. New York Asthma Drugs Market

12. Ohio Asthma Drugs Market

13. Pennsylvania Asthma Drugs Market

14. Texas Asthma Drugs Market

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. Aerocrine (Circassia)
16.2. ALK-Abello A/S
16.3. Amphastar Pharmaceuticals, Inc.
16.4. AstraZeneca
16.5. Boehringer Ingelheim
16.6. Camber Pharmaceuticals
16.7. Chiesi Farmaceutici
16.8. Cipla
16.9. Cohero Health
16.10. GlaxoSmithKline PLC
16.11. Inspiro Medical (Opko Health)
16.12. Lallemand Pharma International
16.13. Merck & Co., Inc.
16.14. MundiPharma
16.15. Novartis AG
16.16. Pulmatrix
16.17. Roche Holding AG
16.18. Sanner GmbH
16.19. Sanofi/Regeneron
16.20. Sunovion
16.21. Teva
16.22. Theravance Biopharma|Mylan Inc.
16.23. Vectura Group plc
16.24. Verona Pharma plc

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES ASTHMA DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES ASTHMA DRUGS MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2027
FIGURE 6. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY LONG-TERM CONTROL MEDICATIONS, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY LONG-TERM CONTROL MEDICATIONS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY MEDICATIONS FOR ALLERGY-INDUCED ASTHMA, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY MEDICATIONS FOR ALLERGY-INDUCED ASTHMA, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY QUICK-RELIEF MEDICATIONS (RESCUE MEDICATIONS), 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY QUICK-RELIEF MEDICATIONS (RESCUE MEDICATIONS), BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
FIGURE 13. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2027
FIGURE 15. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES ASTHMA DRUGS MARKET: FPNV POSITIONING MATRIX
FIGURE 22. UNITED STATES ASTHMA DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 23. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES ASTHMA DRUGS MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES ASTHMA DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY LONG-TERM CONTROL MEDICATIONS, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY MEDICATIONS FOR ALLERGY-INDUCED ASTHMA, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY QUICK-RELIEF MEDICATIONS (RESCUE MEDICATIONS), BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES ASTHMA DRUGS MARKET: SCORES
TABLE 12. UNITED STATES ASTHMA DRUGS MARKET: BUSINESS STRATEGY
TABLE 13. UNITED STATES ASTHMA DRUGS MARKET: PRODUCT SATISFACTION
TABLE 14. UNITED STATES ASTHMA DRUGS MARKET: RANKING
TABLE 15. UNITED STATES ASTHMA DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 16. UNITED STATES ASTHMA DRUGS MARKET: MERGER & ACQUISITION
TABLE 17. UNITED STATES ASTHMA DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 18. UNITED STATES ASTHMA DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 19. UNITED STATES ASTHMA DRUGS MARKET: INVESTMENT & FUNDING
TABLE 20. UNITED STATES ASTHMA DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 21. UNITED STATES ASTHMA DRUGS MARKET: LICENSE & PRICING

Companies Mentioned

Aerocrine (Circassia)
ALK-Abello A/S
Amphastar Pharmaceuticals, Inc.
AstraZeneca
Boehringer Ingelheim
Camber Pharmaceuticals
Chiesi Farmaceutici
Cipla
Cohero Health
GlaxoSmithKline PLC
Inspiro Medical (Opko Health)
Lallemand Pharma International
Merck & Co., Inc.
MundiPharma
Novartis AG
Pulmatrix
Roche Holding AG
Sanner GmbH
Sanofi/Regeneron
Sunovion
Teva
Theravance Biopharma|Mylan Inc.
Vectura Group plc
Verona Pharma plc